Donald Browne Net Worth

What's Donald Browne's mailing address?

Donald's mailing address filed with the SEC is C/O BIOSIG TECHNOLOGIES, INC., 12424 WILSHIRE BLVD STE 745, LOS ANGELES, CA, 90025.

Insiders trading at Biosig Technologies Inc

Over the last 9 years, insiders at Biosig Technologies Inc have traded over $1,778,587 worth of Biosig Technologies Inc stock and bought 1,345,515 units worth $2,296,289 . The most active insiders traders include Kenneth L Londoner, Asher Holzer a Jerome B Zeldis. On average, Biosig Technologies Inc executives and independent directors trade stock every 24 days with the average trade being worth of $11,433. The most recent stock trade was executed by Kenneth L Londoner on 13 June 2023, trading 15,600 units of BSGM stock currently worth $19,344.

What does Biosig Technologies Inc do?

biosig technologies, inc. (otcqb: bsgm) is a medical device company that is developing a proprietary technology platform designed to greatly improve the $3 billion electrophysiology (ep) marketplace. led by a proven management team and a veteran, independent board of directors, minneapolis-based biosig is preparing to commercialize its pure ep system.

Biosig Technologies Inc executives and stock owners

Biosig Technologies Inc executives and other stock owners filed with the SEC include:

• Kenneth Londoner,
  Executive Chairman of the Board, Chief Executive Officer
• Steven Chaussy,
  Chief Financial Officer
• Kenneth L. Londoner M.B.A., MBA,
  Founder, CEO & Exec. Chairman
• Samuel Navarro,
  Independent Director
• Jeffrey O'Donnell,
  Lead Independent Director
• Martha Pease,
  Independent Director
• Andrew Filler,
  Independent Director
• David Weild,
  Independent Director
• Patrick Gallagher,
  Independent Director
• Donald Foley,
  Independent Director
• Anthony Zook,
  Director
• Manasi Patwardhan,
  Director of Strategic Planning
• Olivier Chaudoir,
  Senior Director of Marketing
• Julie Stephenson,
  Vice President - Clinical Affairs, Senior Director of Clinical Affairs
• Andrew Ballou,
  Vice President - Investor Relations
• John Kowalski,
  Vice President - Sales
• John Sieckhaus,
  Chief Operating Officer
• Gray Fleming,
  Chief Commercial Officer
• Steven Chaussy,
  Chief Financial Officer
• Natasha Drapeau,
  Exec. VP
• Brenda Castrodad,
  Director of HR
• Lora Mikolaitis,
  VP of Admin.
• Dr. Budimir S. Drakulic Ph.D.,
  Chief Scientist
• Steven Eric Abelman,
  Director
• Steve Chaussy,
  Chief Financial Officer
• Roy T Tanaka,
  Director
• Lora Mikolaitis,
  10% owner
• Seth H. Z. Fischer,
  Director
• Joseph Rafferty,
  Chief Commercialization Offcr
• Jerome B Zeldis,
  Director
• Asher Holzer,
  Director
• Gregory D Cash,
  President and CEO
• James L Klein,
  Director
• James J Barry,
  Director
• John Sieckhaus,
  Chief Operating Officer
• Gray Fleming,
  Chief Commercial Officer
• Steven J Buhaly,
  Chief Financial Officer
• Frederick Hrkac,
  Director
• Donald Browne,
  Director
• Christopher Allen Baer,
  Director